Research ArticleOriginal Article
Open Access

Exploring hypothyroidism’s effects on lipid profiles

Evidence of metabolic consequences in subclinical disease

Haifa M. Alnahdi
Saudi Medical Journal May 2025, 46 (5) 491-496; DOI: https://doi.org/10.15537/smj.2025.46.5.20241147

References

  1. 1.↵
    1. Biondi B,
    2. Cappola AR,
    3. Cooper DS.
    Subclinical hypothyroidism: a review. JAMA 2019; 322: 153-160.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Delitala AP,
    2. Fanciulli G,
    3. Maioli M,
    4. Delitala G.
    Subclinical hypothyroidism, lipid metabolism and cardiovascular disease. Eur J Intern Med 2017; 38: 17-24.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Su X,
    2. Peng H,
    3. Chen X,
    4. Wu X,
    5. Wang B.
    Hyperlipidemia and hypothyroidism. Clin Chim Acta 2022; 527: 61-70.
    OpenUrlCrossRef
  4. 4.↵
    1. Kosmas CE,
    2. Rodriguez Polanco S,
    3. Bousvarou MD,
    4. Papakonstantinou EJ,
    5. Peña Genao E,
    6. Guzman E, et al.
    The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease. Diagnostics (Basel) 2023; 13: 929.
    OpenUrlPubMed
  5. 5.↵
    1. Alnahdi HM,
    2. Mohammed YHI.
    The role of thrombolytic protein therapy in the prevention of microvascular complications in non-insulin-dependent diabetes mellitus: an integrative approach. Romanian J Diabetes NutrMetab Dis 2024; 31: 158-164.
    OpenUrl
  6. 6.
    1. Raposo HF,
    2. Forsythe P,
    3. Chausse B,
    4. Castelli JZ,
    5. Moraes-Vieira PM,
    6. Nunes VS, et al.
    Novel role of cholesteryl ester transfer protein (CETP): attenuation of adiposity by enhancing lipolysis and brown adipose tissue activity. Metabolism 2021; 114: 154429.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Moon JH,
    2. Kim HJ,
    3. Kim HM,
    4. Choi SH,
    5. Lim S,
    6. Park YJ, et al.
    Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism. Thyroid 2013; 23: 1057-1065.
    OpenUrlPubMed
  8. 8.↵
    1. Luo Y,
    2. Wu F,
    3. Huang Z,
    4. Gong Y,
    5. Zheng Y.
    Assessment of the relationship between subclinical hypothyroidism and blood lipid profile: reliable or not? Lipids Health Dis 2022; 21: 137.
    OpenUrlPubMed
  9. 9.↵
    1. Romano S,
    2. Savva GM,
    3. Bedarf JR,
    4. Charles IG,
    5. Hildebrand F,
    6. Narbad A.
    Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 2021; 7: 27.
    OpenUrlPubMed
  10. 10.↵
    1. Cuny T,
    2. Reynaud R,
    3. Raverot G,
    4. Coutant R,
    5. Chanson P,
    6. Kariyawasam D, et al.
    Diagnosis and management of children and adult craniopharyngiomas: a French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes consensus statement. Ann Endocrinol (Paris) 2025; 86: 101631.
    OpenUrlPubMed
  11. 11.↵
    1. S S,
    2. Mb V
    . A study of lipid profile in patients with subclinical hypothyroidism. J Assoc Physicians India 2022; 70: 11-12.
    OpenUrl
  12. 12.↵
    1. Wang X,
    2. Zhang E,
    3. Tian Z,
    4. Zhao R,
    5. Huang K,
    6. Gao S, et al.
    The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study. Lipids Health Dis 2024; 23: 13.
    OpenUrlPubMed
  13. 13.↵
    1. Zhu L,
    2. Jiang X.
    Characteristics of blood lipid and metabolic indicators in subclinical hypothyroidism patients: a retrospective study. Front Med (Lausanne) 2024; 11: 1439626.
    OpenUrlPubMed
  14. 14.↵
    1. Surks MI,
    2. Ortiz E,
    3. Daniels GH,
    4. Sawin CT,
    5. Col NF,
    6. Cobin RH, et al.
    Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-238.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Jonklaas J. Hypothyroidism
    , lipids, and lipidomics. Endocrine 2024; 84: 293-300.
    OpenUrlPubMed
  16. 16.↵
    1. Rajkarnikar S,
    2. Sharma VK,
    3. Baidya S,
    4. Kadel P,
    5. Tuladhar ET,
    6. Niraula A, et al.
    High sensitive C-reactive protein and lipid profile alteration in subclinical hypothyroidism for cardiovascular risk assessment. J Nepal Health Res Counc 2024; 22: 306-310.
    OpenUrlPubMed
  17. 17.↵
    1. Hewage N,
    2. Wijesekara U,
    3. Perera R.
    Prevalence of subclinical hypothyroidism in a non-diabetic young female population and its impact on diabetes and cardiometabolic risk. Endocrinol Metab (Seoul) 2024; 39: 864-876.
    OpenUrlPubMed
  18. 18.↵
    1. Liu J,
    2. Chen Y,
    3. Ren B,
    4. He Y,
    5. Li F,
    6. Wang L, et al.
    Alteration of lipid profile between subclinical hypothyroidism and well-matched controls: a meta-analysis. Horm Metab Res 2023; 55: 479-486.
    OpenUrlPubMed
  19. 19.↵
    1. Ni W,
    2. Zhang M,
    3. Wang X,
    4. Li X,
    5. Wang Q,
    6. Wang Y, et al.
    Age-specific serum thyrotropin reference range for the diagnosis of subclinical hypothyroidism and its association with lipid profiles in the elderly population. Sci Rep 2022; 12: 20872.
    OpenUrlPubMed
  20. 20.↵
    1. Monterrosa-Castro Á,
    2. Monterrosa-Blanco A,
    3. Sánchez-Zarza S.
    Possible association between subclinical hypothyroidism and age at menopause in Colombian women. Gynecol Endocrinol 2024; 40: 2334798.
    OpenUrlPubMed
  21. 21.↵
    1. Razvi S,
    2. Shakoor A,
    3. Vanderpump M,
    4. Weaver JU,
    5. Pearce SH.
    The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 2008; 93: 2998-3007.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Surks MI,
    2. Hollowell JG.
    Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92: 4575-4582.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Taylor PN,
    2. Lansdown A,
    3. Witczak J,
    4. Khan R,
    5. Rees A,
    6. Dayan CM, et al.
    Age-related variation in thyroid function - a narrative review highlighting important implications for research and clinical practice. Thyroid Res 2023; 16: 7.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Pokhrel S,
    2. Baral N,
    3. Sridhar MG,
    4. Lamsal M.
    Age related changes in cholesterol level among the patients with subclinical hypothyroidism in eastern Nepal. Nepal Med Coll J 2006; 8: 185-189.
    OpenUrlPubMed
  25. 25.↵
    1. Zhu L,
    2. Jiang X.
    Characteristics of blood lipid and metabolic indicators in subclinical hypothyroidism patients: a retrospective study. Front Med (Lausanne) 2024; 11: 1439626.
    OpenUrlPubMed
  26. 26.↵
    1. Alzahrani MA,
    2. Baqar FS,
    3. Alzahrani BA,
    4. Badri ZA,
    5. Alshamrani R,
    6. Aljuhani J.
    Impact of subclinical hypothyroidism on lipid profile in Jeddah: a retrospective cohort study. Cureus 2024; 16: e65433.
    OpenUrlPubMed
  27. 27.↵
    1. Harrar S,
    2. Mhirig I,
    3. El Alaoui Boufares Y,
    4. Bouchehboun A,
    5. Bounani F,
    6. Aboulmakarim S.
    Lipid profile perturbations associated with subclinical hypothyroidism: a descriptive study. Cureus 2024; 16: e58181.
    OpenUrlPubMed
  28. 28.↵
    1. Zhang X,
    2. Li Y,
    3. Jin J,
    4. Wang H,
    5. Zhao B,
    6. Wang S, et al.
    The different outcomes in the elderly with subclinical hypothyroidism diagnosed by age-specific and non-age-specific TSH reference intervals: a prospectively observational study protocol. Front Endocrinol (Lausanne) 2023; 14: 1242110.
    OpenUrlPubMed
  29. 29.↵
    1. Kang C,
    2. Liu J,
    3. Zheng Y,
    4. Wang X,
    5. Yang L,
    6. Qiu S, et al.
    Association of high BMI with subclinical hypothyroidism in young, first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study. Eur Arch Psychiatry Clin Neurosci 2023; 273: 183-190.
    OpenUrlPubMed
  30. 30.
    1. Luo Y,
    2. Wu F,
    3. Huang Z,
    4. Gong Y,
    5. Zheng Y.
    Assessment of the relationship between subclinical hypothyroidism and blood lipid profile: reliable or not? Lipids Health Dis 2022; 21: 137.
    OpenUrlPubMed
  31. 31.↵
    1. Pergialiotis V,
    2. Konstantopoulos P,
    3. Prodromidou A,
    4. Florou V,
    5. Papantoniou N,
    6. Perrea DN.
    Management of endocrine disease: the impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis. Eur J Endocrinol 2017; 176: R159-R166.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Velkoska Nakova V,
    2. Krstevska B,
    3. Bosevski M,
    4. Dimitrovski Ch,
    5. Serafimoski V.
    Dyslipidaemia and hypertension in patients with subclinical hypothyroidism. Prilozi 2009; 30: 93-102.
    OpenUrlPubMed
  33. 33.↵
    1. Brenta G,
    2. Mutti LA,
    3. Schnitman M,
    4. Fretes O,
    5. Perrone A,
    6. Matute ML.
    Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 2003; 91: 1327-1330.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Duan Y,
    2. Wang X,
    3. Peng W,
    4. Feng Y,
    5. Tang W,
    6. Wu X, et al.
    Gender-specific associations between subclinical hypothyroidism and blood pressure in Chinese adults. Endocrine 2009; 36: 438-444.
    OpenUrlPubMed
  35. 35.↵
    1. Zhong F,
    2. Guan Q,
    3. Zhang H,
    4. Zhang X,
    5. Zhao M,
    6. Yuan Z, et al.
    Association of longitudinal changes in serum lipids with the natural history of subclinical hypothyroidism: a retrospective cohort study using data from the REACTION study. EClinicalMedicine 2022; 53: 101629.
    OpenUrlPubMed
  36. 36.↵
    1. Gao M,
    2. Cao L,
    3. Wang H,
    4. Peng R,
    5. Xiao X,
    6. Wang G,
    7. Gao Y,
    8. Wang G,
    9. Sun C.
    Correlation between subclinical hypothyroidism and dyslipidemia in women in northeast China. Acta Endocrinol (Buchar) 2021; 17: 282-285.
    OpenUrlPubMed
  37. 37.↵
    1. Zhao C,
    2. Wang Y,
    3. Xiao L,
    4. Li L.
    Effect of levothyroxine on older patients with subclinical hypothyroidism: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2022; 13: 913749.
    OpenUrlPubMed
  38. 38.↵
    1. Gonzalez Gil L,
    2. de la Sierra A.
    Prevalence of hypertension and other cardiovascular risk factors in subjects with subclinical hypothyroidism. Med Clin (Barc) 2017; 148: 351-353.
    OpenUrlPubMed
  39. 39.↵
    1. Liu P,
    2. Liu R,
    3. Chen X,
    4. Chen Y,
    5. Wang D,
    6. Zhang F, et al.
    Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study. Curr Med Res Opin 2015; 31: 2233-2240.
    OpenUrlPubMed
  40. 40.↵
    1. Chang YC,
    2. Chang CH,
    3. Yeh YC,
    4. Chuang LM,
    5. Tu YK.
    Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study. Sci Rep 2018; 8: 2031.
    OpenUrlPubMed
  41. 41.↵
    1. Alharazi RM,
    2. Almarri LK,
    3. Ibrahim HM,
    4. Abdulshakour LS,
    5. Ahmad MA,
    6. Bashool RA.
    Awareness of thyroid diseases and their risk factors among the residents of Jeddah, Saudi Arabia. Cureus 2024; 16: e62113.
    OpenUrlPubMed
  42. 42.↵
    1. Van Uytfanghe K,
    2. Ehrenkranz J,
    3. Halsall D,
    4. Hoff K,
    5. Loh TP,
    6. Spencer CA, et al.
    Thyroid stimulating hormone and thyroid hormones (triiodothyronine and thyroxine): an American Thyroid Association-commissioned review of current clinical and laboratory status. Thyroid 2023; 33: 1013-1028.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords